Dispensaries and delivery services buckled under the pressure of the ever-growing celebration.
Cannabis' famed pacifying properties could make it an excellent candidate for future pharmaceuticals to treat PTSD.
A significant minority of major depressive disorder patients don’t respond to currently available antidepressant medication. A newly approved treatment, based on the "club drug" ketamine, could change that. In a session at the British Neuroscience Association’s Festival of Neuroscience 2019, the potential mechanisms of ketamine’s antidepressant action were put under examination.
US military veterans would be able to consume legal cannabis without forfeiting their federal benefits under a new bipartisan bill.
The southeast Asian country could soon become the second in its region to approve medical cannabis for its citizens.
Economic reports show how the country's legal cannabis market is soaring but still under-performing against its unregulated rival.
Marijuana's taking the leap from campus contraband to syllabus subject. But what can students expect to learn?
The political union could soon boost its hemp-THC limit to 0.3 percent to match the standards of other countries, like the US and Canada.
The scientific researchers of cannabis could be studying a plant far less potent than the one many readily consume.